What Can Chemical Carcinogenesis Shed Light on the LNT Hypothesis in Radiation Carcinogenesis?
James E TroskoPublished in: Dose-response : a publication of International Hormesis Society (2019)
To protect the public's health from exposure to physical, chemical, and microbiological agents, it is important that any policy be based on rigorous scientifically based research. The concept of "linear no-threshold" (LNT) has been implemented to provide guideline exposures to these agents. The practical limitation to testing this hypothesis is to provide sufficient samples for experimental or epidemiological studies. While there is no universally accepted understanding of most human diseases, there seems to be better understanding of cancer that might help resolve the "LNT" model. The public's concern, after being exposed to radiation, is the potential of producing cancer. The most rigorous hypothesis of human carcinogenesis is the "multistage, multimechanism" chemical carcinogenesis model. The radiation carcinogenesis LNT model, rarely, if ever, built it into their support. It will be argued that this multistage, multimechanism model of carcinogenesis, involving the "initiation" of a single cell by a mutagen event, followed by chronic exposure to threshold levels of epigenetic agents or conditions that stimulate the clonal expansion of the "initiated" cell, can convert these benign cells to become invasive and metastatic. This "promotion" process can be interrupted, thereby preventing these initiated cells from transitioning to the "progression" process of invasion and metastasis.
Keyphrases
- single cell
- healthcare
- mental health
- endothelial cells
- public health
- papillary thyroid
- small cell lung cancer
- gene expression
- induced apoptosis
- squamous cell carcinoma
- emergency department
- rna seq
- dna methylation
- physical activity
- air pollution
- radiation induced
- cell migration
- health information
- endoplasmic reticulum stress
- electronic health record
- pluripotent stem cells
- signaling pathway
- childhood cancer